Mural Oncology PLCNASDAQ:MURA
- LAST PRICE3.8700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.2000/ 2
- Ask / Lots4.2600/ 10
- Open / Previous Close--- / 3.8700
- Day Range---
- 52 Week Range
- Volume4,674
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MURA |
|---|---|---|
| 09:32 ET | 112416 | 3.86 |
| 09:33 ET | 42738 | 3.8138 |
| 09:35 ET | 25772 | 3.81 |
| 09:37 ET | 58992 | 3.885 |
| 09:39 ET | 51826 | 4.0099 |
| 09:42 ET | 24794 | 4.01 |
| 09:44 ET | 55086 | 4.03 |
| 09:46 ET | 50784 | 4.0464 |
| 09:48 ET | 28434 | 4.099 |
| 09:50 ET | 35256 | 4.0489 |
| 09:51 ET | 28700 | 3.98 |
| 09:53 ET | 10823 | 3.99 |
| 09:55 ET | 17104 | 4 |
| 09:57 ET | 27538 | 3.9103 |
| 10:00 ET | 16185 | 3.92 |
| 10:02 ET | 23288 | 3.95 |
| 10:04 ET | 5255 | 3.96 |
| 10:06 ET | 11484 | 3.9789 |
| 10:08 ET | 10075 | 3.99 |
| 10:09 ET | 17241 | 4.025 |
| 10:11 ET | 37993 | 4.0483 |
| 10:13 ET | 26100 | 4.07 |
| 10:15 ET | 45284 | 4.135 |
| 10:18 ET | 8415 | 4.11 |
| 10:20 ET | 1950 | 4.145 |
| 10:22 ET | 26607 | 4.1 |
| 10:24 ET | 4138 | 4.11 |
| 10:26 ET | 18828 | 4.1101 |
| 10:27 ET | 34185 | 4.205 |
| 10:29 ET | 28366 | 4.25 |
| 10:31 ET | 20033 | 4.2 |
| 10:33 ET | 14146 | 4.18 |
| 10:36 ET | 13950 | 4.23 |
| 10:38 ET | 9422 | 4.16 |
| 10:40 ET | 5629 | 4.165 |
| 10:42 ET | 10218 | 4.2352 |
| 10:44 ET | 26338 | 4.2482 |
| 10:45 ET | 25896 | 4.2334 |
| 10:47 ET | 10436 | 4.23 |
| 10:49 ET | 1112 | 4.245 |
| 10:51 ET | 2154 | 4.2315 |
| 10:54 ET | 17640 | 4.25 |
| 10:56 ET | 19877 | 4.2299 |
| 10:58 ET | 31618 | 4.075 |
| 11:00 ET | 8648 | 4.075 |
| 11:02 ET | 10155 | 4.07 |
| 11:03 ET | 3603 | 4.15 |
| 11:05 ET | 2409 | 4.155 |
| 11:07 ET | 3647 | 4.14 |
| 11:09 ET | 8248 | 4.1 |
| 11:12 ET | 1361 | 4.08 |
| 11:14 ET | 900 | 4.06 |
| 11:16 ET | 2130 | 4.11 |
| 11:18 ET | 8883 | 4.19 |
| 11:20 ET | 7452 | 4.205 |
| 11:21 ET | 7536 | 4.24 |
| 11:23 ET | 788 | 4.2 |
| 11:25 ET | 2403 | 4.2385 |
| 11:30 ET | 8935 | 4.2 |
| 11:32 ET | 10798 | 4.1543 |
| 11:34 ET | 3419 | 4.15 |
| 11:36 ET | 4955 | 4.1993 |
| 11:38 ET | 10600 | 4.18 |
| 11:39 ET | 3139 | 4.17 |
| 11:41 ET | 300 | 4.1899 |
| 11:43 ET | 1560 | 4.18 |
| 11:45 ET | 4378 | 4.17 |
| 11:48 ET | 7228 | 4.1201 |
| 11:50 ET | 2607 | 4.12 |
| 11:52 ET | 2200 | 4.14 |
| 11:54 ET | 6151 | 4.15 |
| 11:56 ET | 100 | 4.13 |
| 11:57 ET | 419 | 4.13 |
| 11:59 ET | 1100 | 4.14 |
| 12:01 ET | 1249 | 4.15 |
| 12:03 ET | 4694 | 4.16 |
| 12:06 ET | 9000 | 4.15 |
| 12:08 ET | 4809 | 4.15 |
| 12:10 ET | 5654 | 4.1412 |
| 12:12 ET | 1189 | 4.14 |
| 12:14 ET | 12885 | 4.13 |
| 12:15 ET | 4964 | 4.12 |
| 12:17 ET | 2105 | 4.1499 |
| 12:19 ET | 5000 | 4.14 |
| 12:21 ET | 2554 | 4.15 |
| 12:26 ET | 2933 | 4.12 |
| 12:28 ET | 1150 | 4.1111 |
| 12:30 ET | 12970 | 4.06 |
| 12:32 ET | 1059 | 4.065 |
| 12:33 ET | 544 | 4.06 |
| 12:35 ET | 11369 | 4.11 |
| 12:37 ET | 1400 | 4.09 |
| 12:39 ET | 943 | 4.1088 |
| 12:42 ET | 1014 | 4.11 |
| 12:44 ET | 1371 | 4.1 |
| 12:46 ET | 200 | 4.1 |
| 12:48 ET | 9189 | 4.08 |
| 12:50 ET | 10798 | 4.04 |
| 12:51 ET | 3599 | 4.04 |
| 12:53 ET | 1600 | 4.01 |
| 12:55 ET | 3000 | 4.02 |
| 12:57 ET | 1218 | 4.05 |
| 01:00 ET | 1935 | 4.02 |
| 01:02 ET | 300 | 4.01 |
| 01:04 ET | 1500 | 4.01 |
| 01:06 ET | 3525 | 4.01 |
| 01:08 ET | 300 | 4.03 |
| 01:09 ET | 2510 | 4.0799 |
| 01:11 ET | 1400 | 4.045 |
| 01:13 ET | 5200 | 4.03 |
| 01:15 ET | 9985 | 4.055 |
| 01:18 ET | 2859 | 4.04 |
| 01:20 ET | 5020 | 4.055 |
| 01:22 ET | 890 | 4.03 |
| 01:24 ET | 500 | 4.03 |
| 01:26 ET | 2212 | 4.01 |
| 01:27 ET | 611 | 4.02 |
| 01:29 ET | 300 | 4.03 |
| 01:31 ET | 700 | 4.045 |
| 01:33 ET | 765 | 4.04 |
| 01:36 ET | 1700 | 4.035 |
| 01:38 ET | 1539 | 4.0415 |
| 01:40 ET | 13273 | 4.055 |
| 01:42 ET | 4909 | 4.05 |
| 01:44 ET | 850 | 4.06 |
| 01:45 ET | 1798 | 4.05 |
| 01:47 ET | 4336 | 4.04 |
| 01:51 ET | 333 | 4.05 |
| 01:54 ET | 950 | 4.04 |
| 01:56 ET | 6079 | 4.0399 |
| 01:58 ET | 26506 | 3.95 |
| 02:00 ET | 3376 | 3.965 |
| 02:02 ET | 1417 | 3.9514 |
| 02:03 ET | 2094 | 3.95 |
| 02:05 ET | 1400 | 3.955 |
| 02:07 ET | 1300 | 3.94 |
| 02:09 ET | 760 | 3.9693 |
| 02:12 ET | 800 | 3.98 |
| 02:14 ET | 3757 | 4.015 |
| 02:16 ET | 400 | 4.0189 |
| 02:18 ET | 2300 | 4.02 |
| 02:20 ET | 300 | 4.0197 |
| 02:21 ET | 2074 | 4.0114 |
| 02:23 ET | 2576 | 4.01 |
| 02:25 ET | 1000 | 4.01 |
| 02:27 ET | 21697 | 4 |
| 02:30 ET | 6069 | 4.01 |
| 02:32 ET | 1421 | 3.99 |
| 02:34 ET | 500 | 4 |
| 02:36 ET | 220 | 3.99 |
| 02:38 ET | 200 | 3.98 |
| 02:39 ET | 1000 | 3.9937 |
| 02:41 ET | 6100 | 3.95 |
| 02:43 ET | 15745 | 3.96 |
| 02:48 ET | 1000 | 3.95 |
| 02:50 ET | 1100 | 3.95 |
| 02:52 ET | 200 | 3.94 |
| 02:56 ET | 2562 | 3.94 |
| 02:57 ET | 4185 | 3.96 |
| 02:59 ET | 400 | 3.93 |
| 03:01 ET | 3857 | 3.9517 |
| 03:03 ET | 100 | 3.93 |
| 03:06 ET | 300 | 3.9586 |
| 03:08 ET | 100 | 3.93 |
| 03:10 ET | 100 | 3.93 |
| 03:12 ET | 400 | 3.93 |
| 03:14 ET | 400 | 3.94 |
| 03:15 ET | 1100 | 3.95 |
| 03:17 ET | 500 | 3.95 |
| 03:19 ET | 200 | 3.95 |
| 03:21 ET | 588 | 3.95 |
| 03:24 ET | 1488 | 3.95 |
| 03:26 ET | 100 | 3.94 |
| 03:28 ET | 308 | 3.9506 |
| 03:30 ET | 1618 | 3.94 |
| 03:32 ET | 1050 | 3.95 |
| 03:33 ET | 1456 | 3.93 |
| 03:35 ET | 1600 | 3.96 |
| 03:37 ET | 3200 | 3.965 |
| 03:39 ET | 7063 | 3.97 |
| 03:42 ET | 8329 | 3.96 |
| 03:44 ET | 6134 | 3.96 |
| 03:46 ET | 4150 | 3.96 |
| 03:48 ET | 8955 | 3.93 |
| 03:50 ET | 5802 | 3.9 |
| 03:51 ET | 375 | 3.9167 |
| 03:53 ET | 18892 | 3.88 |
| 03:55 ET | 6188 | 3.86 |
| 03:57 ET | 3370 | 3.86 |
| 04:00 ET | 42410 | 3.87 |
Nov 20, 2024
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer, from 4:15PM ET on Wednesday Nov 20, 2024 by Dow Jones
4:15PM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 14, 2024
DJ Mural Oncology Price Target Maintained With a $18.00/Share by HC Wainwright & Co., from 5:00AM ET on Thursday Nov 14, 2024 by Dow Jones
5:00AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
Press Release: Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow JonesMural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 11, 2024
Mural Oncology to Participate in Two Upcoming Investor Conferences, from 7:00AM ET on Monday Nov 11, 2024 by Dow Jones
7:00AM ET on Monday Nov 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mural Oncology PLC | 57.2M | -0.4x | --- |
X4 Pharmaceuticals Inc | 57.6M | -3.9x | --- |
Entera Bio Ltd | 58.6M | -6.4x | --- |
Connect Biopharma Holdings Ltd | 55.3M | -2.5x | --- |
enVVeno Medical Corp | 59.8M | -2.5x | --- |
Vor Biopharma Inc | 54.3M | -0.5x | --- |
Company Information
Mural Oncology plc is Ireland-based clinical-stage oncology company. The Company is leveraging its protein engineering platform to develop cytokine-based immunotherapies for the treatment of cancer. It leverages its in-cytokine biology, immune cell modulation and protein engineering capabilities to develop immunotherapies. The Company is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers, particularly those with limited treatment options available. Its portfolio of programs includes Nemvaleukin alfa (Nemvaleukin)-IL-2, IL-12, and IL-18. Nemvaleukin is an engineered interleukin-2 (IL-2) variant designed to harness the potent anti-cancer capabilities of high-dose rhIL-2 while minimizing toxicity by selectively activating cancer-fighting CD8 T cells and NK cells. The tumor-targeted split IL-12 program focuses on delivering the therapeutic potential of IL-12 by splitting it into inactive component.
Contact Information
- Headquarters
- 10 Earlsfort TerraceDUBLIN, Ireland D02 T380
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Scott Jackson
- President, Chief Executive Officer, Director
- Caroline Loew
- Chief Financial Officer
- Adam Cutler
- Chief Medical Officer
- Vicki Goodman
- Chief Legal Officer
- Maiken Keson-Brookes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $57.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 17.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-9.14 |
Book Value | $15.81 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
